Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin
NCT02197078
·
clinicaltrials.gov ↗
COMPLETED
Status
189426
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Sponsor
Boehringer Ingelheim
Collaborators
[object Object]